Evidence map›Paper›PMID 29950411›Full record

ArticleJournal of virology2018

Human MxB Protein Is a Pan-herpesvirus Restriction Factor.

Mirjam Schilling, Lorenzo Bulli, Sebastian Weigang, Laura Graf, Sebastian Naumann, Corinna Patzina, Valentina Wagner, Liane Bauersfeld, Caroline Goujon, Hartmut Hengel and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 111 citations in OpenAlex.

  1. Article
  2. Expulsion of nuclear DNA to the cytoplasm after viral entry: A mechanism for activation of the cGAS pathway.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Sumac Polyphenols as Pan-Herpesvirus Inhibitors.International journal of molecular sciences · 2025
    Article
  9. Article
  10. Antiviral Mx proteins have an ancient origin and widespread distribution among eukaryotes.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Nuclear interferon-stimulated gene product maintains heterochromatin on the herpes simplex viral genome to limit lytic infection.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Mirjam SchillingInstitute of Virology, Medical Center-University of Freiburg, Freiburg, Germany.
Lorenzo BulliDepartment of Infectious Diseases, Institute of Virology, University Hospital Heidelberg, Heidelberg, Germany.
Sebastian WeigangInstitute of Virology, Medical Center-University of Freiburg, Freiburg, Germany.
Laura GrafInstitute of Virology, Medical Center-University of Freiburg, Freiburg, Germany.
Sebastian NaumannInstitute of Virology, Medical Center-University of Freiburg, Freiburg, Germany.
Corinna PatzinaInstitute of Virology, Medical Center-University of Freiburg, Freiburg, Germany.
Valentina WagnerInstitute of Virology, Medical Center-University of Freiburg, Freiburg, Germany.
Liane BauersfeldInstitute of Virology, Medical Center-University of Freiburg, Freiburg, Germany.
Caroline GoujonInstitut de Recherche en Infectiologie de Montpellier, UMR9004, CNRS-Montpellier University, Montpellier, France.
Hartmut HengelInstitute of Virology, Medical Center-University of Freiburg, Freiburg, Germany.
Anne HaleniusInstitute of Virology, Medical Center-University of Freiburg, Freiburg, Germany.
Zsolt RuzsicsInstitute of Virology, Medical Center-University of Freiburg, Freiburg, Germany.
Torsten SchallerDepartment of Infectious Diseases, Institute of Virology, University Hospital Heidelberg, Heidelberg, Germany.ORCID https://orcid.org/0000-0001-9597-4112
Georg KochsInstitute of Virology, Medical Center-University of Freiburg, Freiburg, Germany georg.kochs@uniklinik-freiburg.de.ORCID https://orcid.org/0000-0003-0187-559X
University of Freiburg · DEHeidelberg University · DECentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herpesvirus infections are highly prevalent in the human population and persist for life. They are often acquired subclinically but potentially progress to life-threatening diseases in immunocompromised individuals. The interferon system is indispensable for the control of herpesviral replication. However, the responsible antiviral effector mechanisms are not well characterized. The type I interferon-induced, human myxovirus resistance 2 (

Indexed as

MutationA549 CellsHerpesviridaeHerpesviridae InfectionsHumansImmunity, InnateInterferonsMyxovirus Resistance ProteinsVirus ReplicationInterferonsMX2 protein, humanMyxovirus Resistance ProteinscytomegalovirusHCMVherpes simplex virusherpesvirusesHSV-1human MX2 geneinnate immunityinterferonsMHV68MxB protein

Identifiers

PMID29950411
PMCPMC6096802
OpenAlexW2810169082

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.